Article Details

India's First mRNA Vaccine: DCGI Approves Phase 2/3 Clinical Trials - Odisha Bytes

Retrieved on: 2021-08-24 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

India's First mRNA Vaccine: DCGI Approves Phase 2/3 Clinical Trials - Odisha Bytes. View article details on hiswai:

Excerpt

New Delhi: India's first COVID-19 mRNA vaccine has been given the go-ahead from the Director Controller General of India to move into the phase 2/3 clinical ...

Article found on: odishabytes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up